FYERS
Home
/
Stocks
/
Results
/
Orchid Pharma Results

Orchid Pharma Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
4%22%23%-12%
---40%-92%
-22%29%46%
-22%4%7%1%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
ORCHPHARMA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
1,096.15₹6609 Cr762.660.547.75₹10 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007Mar 2006
————————————————————
₹15 Cr₹15 Cr₹51 Cr₹41 Cr₹41 Cr₹41 Cr₹41 Cr₹89 Cr₹89 Cr₹89 Cr₹89 Cr₹85 Cr₹70 Cr₹70 Cr₹70 Cr₹70 Cr₹70 Cr₹66 Cr₹66 Cr₹65 Cr
₹45 Cr₹45 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹96,000₹0
₹1504 Cr₹1494 Cr₹1119 Cr₹648 Cr₹607 Cr₹612 Cr₹725 Cr-₹793 Cr-₹881 Cr-₹477 Cr-₹40 Cr₹244 Cr₹310 Cr₹1062 Cr₹999 Cr₹867 Cr₹563 Cr₹599 Cr₹419 Cr₹711 Cr
₹1504 Cr₹1494 Cr₹1119 Cr₹648 Cr₹607 Cr₹612 Cr₹725 Cr-₹793 Cr-₹881 Cr-₹477 Cr-₹40 Cr₹244 Cr₹310 Cr₹1062 Cr₹999 Cr₹867 Cr₹563 Cr₹599 Cr₹419 Cr₹711 Cr
₹1564 Cr₹1554 Cr₹1169 Cr₹689 Cr₹647 Cr₹653 Cr₹766 Cr-₹704 Cr-₹792 Cr-₹388 Cr₹49 Cr₹329 Cr₹380 Cr₹1132 Cr₹1069 Cr₹938 Cr₹634 Cr₹665 Cr₹485 Cr₹776 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹62 L₹3 Cr₹2 Cr₹0₹0₹0₹0₹0
₹185 Cr₹3 L₹22 L₹40 Cr₹111 Cr₹342 Cr₹430 Cr₹1425 Cr₹1894 Cr₹2157 Cr₹2378 Cr₹2494 Cr₹902 Cr₹1074 Cr₹604 Cr₹1036 Cr₹1714 Cr₹980 Cr₹707 Cr₹843 Cr
₹0₹10 Cr₹120 Cr₹109 Cr₹97 Cr₹86 Cr₹74 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹625 Cr₹902 Cr₹991 Cr₹942 Cr₹202 Cr
-₹29 L-₹10 L₹0₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹46 Cr₹94 Cr₹111 Cr₹157 Cr₹170 Cr₹194 Cr₹203 Cr₹128 Cr₹115 Cr₹92 Cr₹80 Cr
₹5 Cr₹4 L₹37 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹42 Cr₹0₹0₹0₹0₹0
₹13 Cr₹5 Cr₹4 Cr₹13 Cr₹11 Cr₹12 Cr₹12 Cr₹8 Cr₹7 Cr₹2 Cr₹4 Cr₹4 Cr₹5 Cr₹8 Cr₹10 Cr₹0₹0₹0₹0₹0
₹203 Cr₹15 Cr₹124 Cr₹165 Cr₹222 Cr₹442 Cr₹519 Cr₹1436 Cr₹1905 Cr₹2205 Cr₹2475 Cr₹2609 Cr₹1064 Cr₹1252 Cr₹850 Cr₹1864 Cr₹2744 Cr₹2085 Cr₹1741 Cr₹1125 Cr
————————————————————
₹347 Cr₹336 Cr₹230 Cr₹174 Cr₹168 Cr₹110 Cr₹102 Cr₹302 Cr₹359 Cr₹425 Cr₹374 Cr₹311 Cr₹597 Cr₹447 Cr₹335 Cr₹318 Cr₹390 Cr₹296 Cr₹235 Cr₹216 Cr
₹56 Cr₹27 Cr₹14 Cr₹53 Cr₹47 Cr₹26 Cr₹70 Cr₹1344 Cr₹958 Cr₹476 Cr₹285 Cr₹113 Cr₹1053 Cr₹407 Cr₹1005 Cr₹294 Cr₹369 Cr₹359 Cr₹389 Cr₹23 Cr
₹88 Cr₹143 Cr₹14 Cr₹141 Cr₹23 Cr₹3 Cr₹0₹695 Cr₹694 Cr₹600 Cr₹634 Cr₹647 Cr₹1525 Cr₹647 Cr₹490 Cr₹0₹0₹0₹0₹0
₹80 L₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr₹1 Cr₹40 Cr₹44 Cr₹52 Cr₹31 Cr₹50 Cr₹159 Cr₹360 Cr₹97 Cr₹78 Cr₹42 Cr₹30 Cr
₹491 Cr₹509 Cr₹260 Cr₹372 Cr₹241 Cr₹142 Cr₹175 Cr₹2346 Cr₹2013 Cr₹1541 Cr₹1338 Cr₹1123 Cr₹3206 Cr₹1551 Cr₹1989 Cr₹972 Cr₹856 Cr₹734 Cr₹665 Cr₹268 Cr
₹2258 Cr₹2077 Cr₹1554 Cr₹1225 Cr₹1111 Cr₹1237 Cr₹1460 Cr₹3077 Cr₹3125 Cr₹3358 Cr₹3862 Cr₹4061 Cr₹4651 Cr₹3938 Cr₹3910 Cr₹3774 Cr₹4234 Cr₹3484 Cr₹2891 Cr₹2169 Cr
₹25 Cr₹18 Cr₹57 Cr₹42 Cr₹43 Cr₹45 Cr₹0₹143 Cr₹162 Cr₹141 Cr₹71 Cr₹107 Cr₹168 Cr₹531 Cr₹322 Cr₹405 Cr₹365 Cr₹385 Cr₹269 Cr₹303 Cr
₹301 Cr₹153 Cr₹134 Cr₹331 Cr₹268 Cr₹453 Cr₹566 Cr₹3230 Cr₹3202 Cr₹3106 Cr₹3215 Cr₹3211 Cr₹3204 Cr₹2005 Cr₹2079 Cr₹1661 Cr₹2616 Cr₹1971 Cr₹1649 Cr₹1045 Cr
————————————————————
₹1517 Cr₹1499 Cr₹1301 Cr₹1221 Cr₹1176 Cr₹1176 Cr₹1247 Cr₹1520 Cr₹1519 Cr₹3006 Cr₹3006 Cr₹3002 Cr₹3772 Cr₹3090 Cr₹2614 Cr₹2345 Cr₹2696 Cr₹2098 Cr₹1563 Cr₹1364 Cr
₹825 Cr₹791 Cr₹681 Cr₹647 Cr₹593 Cr₹506 Cr₹389 Cr₹263 Cr₹133 Cr₹1509 Cr₹1369 Cr₹1207 Cr₹1189 Cr₹1016 Cr₹872 Cr₹741 Cr₹688 Cr₹558 Cr₹458 Cr₹374 Cr
₹692 Cr₹708 Cr₹620 Cr₹573 Cr₹584 Cr₹670 Cr₹858 Cr₹1256 Cr₹1386 Cr₹1497 Cr₹1637 Cr₹1795 Cr₹2584 Cr₹2074 Cr₹1742 Cr₹1603 Cr₹2008 Cr₹1540 Cr₹1105 Cr₹990 Cr
₹341 Cr₹64 Cr₹16 Cr₹46 Cr₹10 Cr₹7 Cr₹15 Cr₹264 Cr₹257 Cr₹274 Cr₹265 Cr₹267 Cr₹332 Cr₹329 Cr₹322 Cr₹469 Cr₹547 Cr₹620 Cr₹553 Cr₹270 Cr
₹67 Cr₹60 Cr₹46 Cr₹44 Cr₹45 Cr₹40 L₹34 L₹47 L₹1 Cr₹96 L₹81 L₹81 L₹95 L₹81 L₹81 L₹0₹0₹0₹0₹0
₹67 Cr₹60 Cr₹46 Cr₹44 Cr₹45 Cr₹40 L₹34 L₹47 L₹1 Cr₹96 L₹81 L₹81 L₹95 L₹81 L₹81 L₹0₹0₹0₹0₹0
₹156 Cr₹131 Cr₹66 Cr₹60 Cr₹74 Cr₹9 Cr₹7 Cr₹765 Cr₹778 Cr₹687 Cr₹681 Cr₹683 Cr₹577 Cr₹221 Cr₹296 Cr₹0₹0₹0₹0₹0
₹2 L₹2 L₹2 L₹0₹74,000₹1 L₹0₹10 Cr₹10 Cr₹6 Cr₹12 Cr₹23 Cr₹28 Cr₹37 Cr₹13 Cr₹0₹0₹0₹0₹0
₹1329 Cr₹980 Cr₹763 Cr₹724 Cr₹713 Cr₹687 Cr₹891 Cr₹2310 Cr₹2446 Cr₹2479 Cr₹2611 Cr₹2783 Cr₹3550 Cr₹2685 Cr₹2384 Cr₹2072 Cr₹2554 Cr₹2160 Cr₹1658 Cr₹1261 Cr
————————————————————
₹0₹0₹0₹0₹0₹15 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹81 L₹81 L₹81 L₹8 L₹8 L
₹372 Cr₹457 Cr₹264 Cr₹229 Cr₹173 Cr₹153 Cr₹142 Cr₹170 Cr₹194 Cr₹211 Cr₹242 Cr₹252 Cr₹506 Cr₹669 Cr₹618 Cr₹423 Cr₹768 Cr₹649 Cr₹612 Cr₹448 Cr
₹381 Cr₹353 Cr₹196 Cr₹215 Cr₹171 Cr₹136 Cr₹68 Cr₹120 Cr₹120 Cr₹203 Cr₹310 Cr₹257 Cr₹179 Cr₹113 Cr₹513 Cr₹737 Cr₹673 Cr₹538 Cr₹383 Cr₹349 Cr
₹84 Cr₹201 Cr₹267 Cr₹31 Cr₹8 Cr₹20 Cr₹174 Cr₹326 Cr₹306 Cr₹257 Cr₹315 Cr₹391 Cr₹23 Cr₹177 Cr₹201 Cr₹335 Cr₹53 Cr₹31 Cr₹119 Cr₹16 Cr
₹17 Cr₹11 Cr₹7 Cr₹4 Cr₹13 Cr₹10 Cr₹22 Cr₹12 Cr₹20 Cr₹9 Cr₹117 Cr₹80 L₹14 Cr₹16 Cr₹9 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr
₹75 Cr₹76 Cr₹57 Cr₹23 Cr₹20 Cr₹96 Cr₹164 Cr₹140 Cr₹40 Cr₹198 Cr₹268 Cr₹378 Cr₹378 Cr₹278 Cr₹185 Cr₹201 Cr₹97 Cr₹102 Cr₹116 Cr₹93 Cr
₹929 Cr₹1097 Cr₹791 Cr₹501 Cr₹384 Cr₹429 Cr₹569 Cr₹767 Cr₹679 Cr₹879 Cr₹1251 Cr₹1278 Cr₹1101 Cr₹1253 Cr₹1526 Cr₹1701 Cr₹1596 Cr₹1324 Cr₹1233 Cr₹908 Cr
₹438 Cr₹589 Cr₹531 Cr₹129 Cr₹144 Cr₹287 Cr₹394 Cr-₹1578 Cr-₹1334 Cr-₹662 Cr-₹86 Cr₹155 Cr-₹2105 Cr-₹298 Cr-₹463 Cr₹729 Cr₹740 Cr₹590 Cr₹568 Cr₹640 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹84 Cr₹0₹0₹0
₹2258 Cr₹2077 Cr₹1554 Cr₹1225 Cr₹1111 Cr₹1237 Cr₹1460 Cr₹3077 Cr₹3125 Cr₹3358 Cr₹3862 Cr₹4061 Cr₹4651 Cr₹3938 Cr₹3910 Cr₹3774 Cr₹4234 Cr₹3484 Cr₹2891 Cr₹2169 Cr
₹993₹987₹231₹169₹159₹160₹188-₹79-₹89-₹44₹6₹39₹54₹161₹152₹133₹78₹101₹74₹120
₹993₹987₹231₹169₹159₹160₹188-₹79-₹89-₹44₹6₹39₹54₹161₹152₹133₹78₹101₹74₹120

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹10 Cr₹122 Cr₹89 Cr₹46 Cr-₹2 Cr-₹117 Cr-₹131 Cr₹69 Cr-₹399 Cr-₹452 Cr-₹296 Cr-₹243 Cr-₹573 Cr₹75 Cr₹172 Cr₹470 Cr-₹34 Cr₹229 Cr₹93 Cr
₹42 Cr₹40 Cr₹44 Cr₹51 Cr₹37 Cr₹172 Cr₹140 Cr₹57 Cr₹453 Cr₹582 Cr₹490 Cr₹1006 Cr₹661 Cr₹334 Cr₹215 Cr-₹557 Cr₹200 Cr₹132 Cr₹189 Cr
₹71 Cr-₹95 Cr-₹8 Cr-₹79 Cr₹60 Cr-₹37 Cr₹62 Cr-₹110 Cr-₹38 Cr₹187 Cr₹18 Cr-₹669 Cr₹79 Cr₹357 Cr₹7 Cr₹119 Cr-₹117 Cr-₹118 Cr-₹184 Cr
₹123 Cr₹67 Cr₹125 Cr₹19 Cr₹94 Cr₹19 Cr₹70 Cr₹16 Cr₹16 Cr₹317 Cr₹212 Cr₹94 Cr₹168 Cr₹766 Cr₹393 Cr₹32 Cr₹49 Cr₹243 Cr₹97 Cr
₹126 Cr₹51 Cr₹126 Cr₹18 Cr₹92 Cr₹24 Cr₹81 Cr₹12 Cr₹9 Cr₹317 Cr₹212 Cr-₹369 Cr₹168 Cr₹737 Cr₹332 Cr-₹34 Cr₹46 Cr₹210 Cr₹96 Cr
-₹277 Cr-₹36 Cr-₹312 Cr-₹31 Cr₹113 Cr₹67 Cr₹167 Cr₹45 Cr-₹28 Cr-₹9 Cr-₹1 Cr₹1334 Cr-₹986 Cr-₹293 Cr-₹367 Cr₹1413 Cr-₹477 Cr-₹545 Cr-₹477 Cr
₹137 Cr₹2 Cr₹167 Cr₹31 Cr-₹217 Cr-₹165 Cr-₹250 Cr-₹30 L₹33 Cr-₹366 Cr-₹286 Cr-₹597 Cr₹664 Cr-₹480 Cr-₹78 Cr-₹1077 Cr₹431 Cr₹247 Cr₹485 Cr
-₹14 Cr₹17 Cr-₹19 Cr₹18 Cr-₹11 Cr-₹74 Cr-₹2 Cr₹57 Cr₹15 Cr-₹58 Cr-₹76 Cr₹367 Cr-₹153 Cr-₹36 Cr-₹113 Cr₹302 Cr₹2 L-₹88 Cr₹104 Cr
₹21 Cr₹4 Cr₹23 Cr₹4 Cr₹16 Cr₹90 Cr₹92 Cr₹35 Cr₹21 Cr₹315 Cr₹391 Cr₹23 Cr₹177 Cr₹213 Cr₹326 Cr₹24 Cr₹24 Cr₹112 Cr₹8 Cr
₹7 Cr₹21 Cr₹4 Cr₹23 Cr₹4 Cr₹16 Cr₹90 Cr₹92 Cr₹35 Cr₹257 Cr₹315 Cr₹391 Cr₹23 Cr₹177 Cr₹213 Cr₹326 Cr₹24 Cr₹24 Cr₹112 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)1,100.00
Volume (₹)9,862.00
High (₹)1,113.30
Upper Circuit1,322.45
Low (₹)1,088.05
Lower Circuit881.65
Prev Close1,102.05
52W High (₹)1,143.50
Price1,110.00
52W Low (₹)480.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)6609.23 Cr
Div. Yield (%)0.00
PE Ratio762.66
Debt to Equity0.20
Price to Book0.48
Book Value993.34
EPS (TTM)1.45
Face Value10.00
ROE (%)0.70

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
ORCHPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1874.6+37.3 (2.03%)
1832.20
1891.50
4,47,476Cr
9614+239 (2.55%)
9312.50
9631
2,54,764Cr
4999+159 (3.29%)
4848.50
5000.50
1,89,423Cr
1171.2+11.2 (0.97%)
1152.10
1178
1,16,658Cr
1381.8-12.7 (-0.91%)
1364.50
1405.20
1,11,484Cr
2047.1+93.1 (4.76%)
1963.80
2050.80
1,09,943Cr
2467+166.3 (7.23%)
2303
2493
1,01,712Cr
1208+23 (1.94%)
1185
1222
1,01,005Cr
1731-3 (-0.17%)
1689.30
1739.30
99,253Cr
2091.7+8.7 (0.42%)
2080
2135
96,031Cr
1110+120.3 (12.16%)
975
1143.50
6,609Cr

Orchid Pharma Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹15.83Cr; with other income of ₹1.83Cr, profit before interest and tax came to ₹4.88Cr. Interest expense was ₹2.23Cr; PBT before exceptional items stood at ₹2.65Cr. Cost mix (full year): raw materials ₹588.07Cr; employee cost ₹86.36Cr; depreciation ₹10.95Cr; other expenses ₹290.17Cr. Basis: consolidated annual results.

Orchid Pharma Ltd Quaterly Results Key Takeaways

Orchid Pharma Ltd reported ₹304.17Cr total income from operations in Jun 2026, softer than ₹237.61Cr in Mar 2026 but higher than ₹263.19Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹15.83Cr; with other income of ₹1.83Cr, profit before interest and tax came to ₹4.88Cr. Interest expense was ₹2.23Cr, taking profit before tax to ₹2.65Cr. After tax of ₹7.2Lakh, profit after tax stood at ₹2.58Cr (vs ₹22.78Cr in Mar 2026 and ₹-₹6.89Cr in Jun 2025).